Redeye is only making minor changes to estimates and valuation following the 2022/23 full year report. Q4 numbers show continued progress, mainly in line with our expectations. Order intake and outlook in now a little softer, but Systemair sees good demand and growth opportunities in several market segments. We are now slightly more cautious in our near-term projections but all and all, impact on our valuation is negligible.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Systemair - Making Further Progress

© Modular Finance, source Nordic Press Releases